SBIR/STTR Research Award

Cell-Free Production of Terpenoid Chemical Astaxanthin Using Crude Cofactor Lysates

Award identifier 27951fbd0298fc4716048c49f91ae11b8774fe62e866a5409ce61a2a88a8581aAwarding agency Department of Energy

Award amount

$1,098,268

Program and phase

SBIR · Phase II

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Energy
Branch
Not reported
Recipient company
INVIZYNE TECHNOLOGIES INC
Proposal award date
2020-08-24
Contract end date
2022-08-23
UEI
UCL9ZV4PLW23
Solicitation number
DE-FOA-0002156
Topic code
08a

Research abstract

Replacing petroleum products with renewable alternatives is important to mitigate pollution and reduce our carbon footprint. Production of renewable products using engineered microorganisms have largely not achieved the yields, titers and productivities required for large scale market adoption. Invizyne Technologies has developed cell-free enzymatic systems that have the potential to increase the overall efficiency of the conversion process and bring down the cost of renewable products. A Techno Economic Analysis identified the cost of using purified cofactors as a main driver of cost of cell-free bioconversions.Bringing down the cost of cofactors will be a critical improvement that will allow for the widespread adoption of this technology. We will bring down the cost of cofactors by developing an alternative process to incorporate crude cofactor mixes from inexpensive waste streams. In phase I we quantified the cofactor pools in industrial strains of yeast and E. coli and demonstrated that they can be effectively integrated into a cell-free enzymatic reaction to make terpenes. We produced a variety of terpenes using crude cofactor lysates as potential products including the long chain carotenoid lycopene which serves as a proof of concept for expansion into other related carotenoids in the future. In phase II we plan to use crude cofactors sourced from industrial yeast to produce an initial carotenoid product called astaxanthin. Our end goal is to produce astaxanthin at industrial relavent titers and scales (10g/L at a 10L scale). Cell free enzymatic bioconversions have the potential to revolutionize the green chemicals industry by lowering the overall cost of production. This cell free approach can also make bio- based chemicals that are impossible to produce in organisms because of their toxicity and therefore can be used to make rare and expensive chemicals more accessible.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

8 SBIR/STTR records share this UEI (2019–2025). Reported award amounts total $5,353,285. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, Department of Energy

Agency intelligence

Department of Energy

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.